Lemonade shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 75 to 89.

Adtran Holdings sees its Relative Strength Rating hit the elite 90-plus level.

U.S. stocks are entering the new year with strong momentum after several years of solid gains. The rally has matured, but has not broken. Inflation has eased, growth expectations are improving, and ...

Wall Street’s rally has been hard to ignore. Since early 2023, stocks have powered higher, with the S&P 500 repeatedly hitting record highs in 2025. Momentum gained further after weak August payroll ...

As of Friday, Neuronetics, Inc.’s STIM share price has dipped by 5.28%, which has investors questioning if this is right time to buy.

Forbes contributors publish independent expert analyses and insights. John Navin is a Colorado-based journalist who writes about stocks. The S&P 500 on Friday hit another new high – it was brief as ...

The Vanguard High Dividend Yield ETF is best held, not bought, as its current yield lags lower-risk alternatives. VYM's appeal lies in its diversified, quality portfolio and relative outperformance ...

As of Friday, March 13, Applied Optoelectronics, Inc.’s AAOI share price has dipped by 5.21%, which has investors questioning ...